358 related articles for article (PubMed ID: 29893459)
1. Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.
Bijelic A; Aureliano M; Rompel A
Angew Chem Int Ed Engl; 2019 Mar; 58(10):2980-2999. PubMed ID: 29893459
[TBL] [Abstract][Full Text] [Related]
2. Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease.
Wang X; Wei S; Zhao C; Li X; Jin J; Shi X; Su Z; Li J; Wang J
J Biol Inorg Chem; 2022 Aug; 27(4-5):405-419. PubMed ID: 35713714
[TBL] [Abstract][Full Text] [Related]
3. Polyoxometalate-Based Organic-Inorganic Hybrids as Antitumor Drugs.
Fu L; Gao H; Yan M; Li S; Li X; Dai Z; Liu S
Small; 2015 Jun; 11(24):2938-45. PubMed ID: 25721026
[TBL] [Abstract][Full Text] [Related]
4. Polyoxometalate-Based Nanomaterials Toward Efficient Cancer Diagnosis and Therapy.
Lu F; Wang M; Li N; Tang B
Chemistry; 2021 Apr; 27(21):6422-6434. PubMed ID: 33314442
[TBL] [Abstract][Full Text] [Related]
5. From Photoinduced to Dark Cytotoxicity through an Octahedral Cluster Hydrolysis.
Svezhentseva EV; Vorotnikov YA; Solovieva AO; Pozmogova TN; Eltsov IV; Ivanov AA; Evtushok DV; Miroshnichenko SM; Yanshole VV; Eling CJ; Adawi AM; Bouillard JG; Kuratieva NV; Fufaeva MS; Shestopalova LV; Mironov YV; Efremova OA; Shestopalov MA
Chemistry; 2018 Dec; 24(68):17915-17920. PubMed ID: 30222219
[TBL] [Abstract][Full Text] [Related]
6. Polyoxometalates functionalized by bisphosphonate ligands: synthesis, structural, magnetic, and spectroscopic characterizations and activity on tumor cell lines.
El Moll H; Zhu W; Oldfield E; Rodriguez-Albelo LM; Mialane P; Marrot J; Vila N; Mbomekallé IM; Rivière E; Duboc C; Dolbecq A
Inorg Chem; 2012 Jul; 51(14):7921-31. PubMed ID: 22725619
[TBL] [Abstract][Full Text] [Related]
7. Polyoxometalate-biomolecule conjugates: a new approach to create hybrid drugs for cancer therapeutics.
Yang HK; Cheng YX; Su MM; Xiao Y; Hu MB; Wang W; Wang Q
Bioorg Med Chem Lett; 2013 Mar; 23(5):1462-6. PubMed ID: 23337597
[TBL] [Abstract][Full Text] [Related]
8. The antibacterial activity of polyoxometalates: structures, antibiotic effects and future perspectives.
Bijelic A; Aureliano M; Rompel A
Chem Commun (Camb); 2018 Jan; 54(10):1153-1169. PubMed ID: 29355262
[TBL] [Abstract][Full Text] [Related]
9. Polyoxometalates in Biomedicine: Update and Overview.
Čolović MB; Lacković M; Lalatović J; Mougharbel AS; Kortz U; Krstić DZ
Curr Med Chem; 2020; 27(3):362-379. PubMed ID: 31453779
[TBL] [Abstract][Full Text] [Related]
10. Polyoxometalate-based nanocomposites for antitumor and antibacterial applications.
Chang D; Li Y; Chen Y; Wang X; Zang D; Liu T
Nanoscale Adv; 2022 Sep; 4(18):3689-3706. PubMed ID: 36133327
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 protease inhibition potential of functionalized polyoxometalates.
Flütsch A; Schroeder T; Grütter MG; Patzke GR
Bioorg Med Chem Lett; 2011 Feb; 21(4):1162-6. PubMed ID: 21256010
[TBL] [Abstract][Full Text] [Related]
12. Molybdenum, Vanadium, and Tungsten-Based Catalysts for Sustainable (ep)Oxidation.
Pisk J; Agustin D
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144747
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor and immunomodulatory activity of iron hepta-tungsten phosphate oxygen clusters complex.
Zhang B; Qiu J; Wu C; Li Y; Liu Z
Int Immunopharmacol; 2015 Dec; 29(2):293-301. PubMed ID: 26590115
[TBL] [Abstract][Full Text] [Related]
14. A Water-Soluble Antimony-Rich Polyoxometalate with Broad-Spectrum Antitumor Activities.
Xiao HP; Hao YS; Li XX; Xu P; Huang MD; Zheng ST
Angew Chem Int Ed Engl; 2022 Oct; 61(41):e202210019. PubMed ID: 35975881
[TBL] [Abstract][Full Text] [Related]
15. Study of antitumor effect of selected vanadium and molybdenum organometallic complexes in human leukemic T-cells.
Šebestová L; Havelek R; Řezáčová M; Honzíček J; Kročová Z; Vinklárek J
Chem Biol Interact; 2015 Dec; 242():61-70. PubMed ID: 26391003
[TBL] [Abstract][Full Text] [Related]
16. Co-assembly of polyoxometalates and peptides towards biological applications.
Gao P; Wu Y; Wu L
Soft Matter; 2016 Oct; 12(41):8464-8479. PubMed ID: 27714298
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of cyclopentadienyltitanium substituted polyoxotungstate [CoW11O39(CpTi)]7- (Cp=eta5-C5H5).
Wang X; Liu J; Li J; Yang Y; Liu J; Li B; Pope MT
J Inorg Biochem; 2003 Mar; 94(3):279-84. PubMed ID: 12628708
[TBL] [Abstract][Full Text] [Related]
18. Exploiting Interactions between Polyoxometalates and Proteins for Applications in (Bio)chemistry and Medicine.
Lentink S; Salazar Marcano DE; Moussawi MA; Parac-Vogt TN
Angew Chem Int Ed Engl; 2023 Aug; 62(31):e202303817. PubMed ID: 37098776
[TBL] [Abstract][Full Text] [Related]
19. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development.
Meier-Menches SM; Gerner C; Berger W; Hartinger CG; Keppler BK
Chem Soc Rev; 2018 Feb; 47(3):909-928. PubMed ID: 29170783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
